TY - CHAP M1 - Book, Section TI - Immunotoxicity A1 - Gill, Amitoj A1 - Gosain, Rahul A2 - Kloecker, Goetz A2 - Arnold, Susanne M. A2 - Fraig, Mostafa M. A2 - Perez, Cesar A. PY - 2021 T2 - Lung Cancer: Standards of Care AB - This case involves a 68-year-old man diagnosed with metastatic non–small cell lung cancer (NSCLC) and adenocarcinoma histology with a programmed death ligand 1 (PDL-1) score of 35%. He completed 4 cycles of carboplatin, pemetrexed, and pembrolizumab combination treatment and is currently on pemetrexed and pembrolizumab maintenance treatment. He presented to the hospital with abdominal cramps, 6-8 episodes of bloody diarrhea in a day, and fatigue. An infectious etiology has been ruled out, and immune-related colitis is speculated. What treatment should be offered to this patient? SN - PB - McGraw-Hill CY - New York, NY Y2 - 2024/03/29 UR - hemonc.mhmedical.com/content.aspx?aid=1176020940 ER -